Medpharm Revenue and Competitors
Estimated Revenue & Valuation
- Medpharm's estimated annual revenue is currently $35M per year.
- Medpharm's estimated revenue per employee is $149,573
Employee Data
- Medpharm has 234 Employees.
- Medpharm grew their employee count by 0% last year.
Medpharm's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer and Co-founder | Reveal Email/Phone |
2 | Head Analytical UK | Reveal Email/Phone |
3 | Head Analytical UK | Reveal Email/Phone |
4 | Head Facilities and Technical Support | Reveal Email/Phone |
5 | Head Process Development | Reveal Email/Phone |
6 | VP Pharmaceutical Development | Reveal Email/Phone |
7 | Head Validation | Reveal Email/Phone |
8 | Head Micro and PT Operations UK | Reveal Email/Phone |
9 | VP Business Development | Reveal Email/Phone |
10 | Senior Director Research Biology & Innovation | Reveal Email/Phone |
What Is Medpharm?
MedPharm is a world-leading contract provider of topical and transdermal product design and development services. Our delivery of robust and innovative research has commanded recognition from regulators and investors alike. We utilise our unique cost-effective performance testing models to mitigate risk and accelerate development times.
keywords:N/AN/A
Total Funding
234
Number of Employees
$35M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Medpharm News
"When we started the program, we had maybe a couple hundred patients at the most," said Stephen Wilson, general manager at MedPharm Iowa. "Now...
... Custer has an engaging discussion with cannabis industry founding father Andy Williams CEO of Medicine Man and MedPharm Holdings.
MedPharm Ltd., a leading provider of contract topical and transdermal product design and formulation development services, is pleased to announce an investment by Ampersand Capital Partners. Since its founding almost 20 years ago, MedPharm has established itself as a trusted developer of topica ...
MedPharm, a Guilford, UK-based developer of topical and transdermal products for drug developers, received an investment from Ampersand Capital Partners. The amount of the deal was not disclosed. The company will use the funds to expand its service offering in topical and transdermal pharmaceu ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $164.9M | 406 | 4% | N/A |